Saturday January 18, 2020

Over Three Lakh Drug Addicts Treated By Punjab Police in 2018

The action plan named Comprehensive Action against Drug Abuse is aimed at choking the supply of drugs through enforcement and reducing the demand through de-addiction and prevention.

0
//
drugs
The action plan named Comprehensive Action against Drug Abuse is aimed at choking the supply of drug

Over three lakh drug addicts were treated in Punjab in 2018 and more than 63,000 people are currently being treated, out of which 25,000 are heroin addicts, a top police official said on Tuesday.

The retention rate is 91.71 per cent, Director General (Special Task Force) Mohammad Mustafa told reporters here.

The Special Task Force, constituted by the state in April 2017, has been implementing a three-pronged strategy of enforcement, de-addiction and prevention (EDP) to combat the menace of drugs.

The action plan named Comprehensive Action against Drug Abuse is aimed at choking the supply of drugs through enforcement and reducing the demand through de-addiction and prevention.

india-china trade
Generic drugs produced by Indian pharmaceutical companies make medicines affordable, but India says that China does not provide market access to its generic drugs. VOA

Mustafa said a multi-layered monitoring and implementing mechanism has been put in place. The Cabinet sub-committee on drugs headed by Chief Minister Amarinder Singh is monitoring it.

He said the outpatient treatment being rendered at 168 Outpatient Outpatient Opioid Assisted Treatment Clinics is a great success.

To make students aware about the ill-effects of drugs, the Buddy Project has been implemented.

Approximately five lakh Drug Abuse Prevention Officers have been registered, 1,500 cluster coordinators and 15,000 Nasha Roku Nigran Committees are being trained through 523 master trainers.

drugs
Over 3 lakh drug addicts treated in Punjab in 2018

Under this project, he said, 329 master trainers are training three lakh school teachers and college lecturers who will impart skills to approximately 40 lakh students.

He said 27 lakh students have already been covered.

A separate drug division is being set up in the Department of Health for efficient drug administration and better monitoring of de-addiction.

The Punjab Chief Minister in October 2018 sought a national drug policy to save the young generation, saying a comprehensive formula was needed at the central level to effectively check the drug abuse.

Punjab CM
Punjab CM Amarinder Singh

Earlier, six northern states unanimously decided to set up a common secretariat, to be based in Panchkula near Chandigarh, for data and information sharing, which was critical to the joint action.

Also Read: Here’s What Causes Cancer in Children

The states that have joined hands are Punjab, Haryana, Himachal Pradesh, Uttarakhand, Rajasthan and Delhi as also the Union Territory of Chandigarh.

The meeting accepted the suggestion of Amarinder Singh to hold regular meetings at various levels to tackle the problem and monitor the progress of the anti-drug fight. (IANS)

Next Story

Cancer Drugs Can Be Used To Treat Pulmonary Diseases: Study

Studies have been investigating the effect of drugs used to treat a variety of cancers on this inflammatory response

0
Cancer
The research discovered that specific cancer drugs inhibit a cell signalling process controlling the death-rate of the harmful neutrophils. Pixabay

Certain class of cancer drugs could be used in the future to treat chronic obstructive pulmonary disease (COPD), say researchers, adding that the drugs could be developed to stop the progression of the disease and promote healing within the lungs.

COPD makes breathing progressively more difficult for millions of people around the world, and the study, published in the journal eLIFE has shown the potential for clinically available cancer treatments to treat it.

“COPD is usually treated with steroids and airway muscle relaxants which ease symptoms, but there is currently no effective treatment clinically available to counteract the damage it does to the lungs,” said study researcher Lynne Prince from the University of Sheffield in UK.

“Our research now shows that inhibitors of these cell signalling processes, or ErbB kinases, could have therapeutic potential in neutrophilic inflammatory disease,” Prince added. According to the researchers, the hope of these drugs is that they can clear the damaging cells from the lungs of people living with COPD, preventing any further damage and therefore the progression of the disease for the first time.

They have been investigating the effect of drugs used to treat a variety of cancers on this inflammatory response; the main driver of lung damage in people living with COPD.

People living with COPD experience a wide range of symptoms that have an increasing impact on their quality of life, including breathlessness, coughing and frequent chest infections. The damage to the lungs is driven by inflammation caused by immune cells called neutrophils.

For the results, the research team screened a library of cancer drugs and identified a number of compounds which accelerate the death of the neutrophil cells and promote healing in the lungs.

The research discovered that specific cancer drugs inhibit a cell signalling process controlling the death-rate of the harmful neutrophils. The team also discovered that editing the genes that encode the cell signalling in the first place, further decreased inflammation.

Cancer
Certain class of cancer drugs could be used in the future to treat chronic obstructive pulmonary disease (COPD), say researchers, adding that the drugs could be developed to stop the progression of the disease and promote healing within the lungs. Pixabay

“As neutrophilic inflammation is also central to the progression of other chronic inflammatory diseases such as rheumatoid arthritis, the research has the potential to impact not only people living with COPD,” said study researcher Stephen Renshaw from the University of Sheffield in UK.

ALSO READ: 80% Medical Students Feel Low Sense of Personal Achievement, Says New Study

“Our next step is to find a way to test these drugs in people with COPD to understand how the ErbB kinase signalling process has an effect on lung inflammation and to address any potential side effects,” Renshaw added. (IANS)